MT Pharmacy

The Empasmart 10 mg tablet is a prescription medication containing empagliflozin, primarily used to manage type 2 diabetes, heart failure, and chronic kidney disease. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. 

Rybelsus 7 mg tablets contain the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes

The Empasmart 25 mg tablet is a prescription medication containing empagliflozin. It is primarily used to manage type 2 diabetes, and also helps treat heart failure and slow the progression of chronic kidney disease. It is an SGLT2 inhibitor that works by helping the kidneys remove excess sugar and salt from the body through urine. 

Victoza (liraglutide) is a prescription prefilled injection pen containing a clear, colorless solution. It is a once-daily, non-insulin medication used to manage type 2 diabetes mellitus in adults and children (10 years and older). It also helps reduce the risk of major adverse cardiovascular events (heart attack, stroke, or death) in adults with type 2 diabetes and established cardiovascular disease. 

The Rybelsus 3 mg tablet is an oval, white to light yellow oral prescription medicine containing the active ingredient semaglutide. It is primarily used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes mellitus. The 3 mg dose is the starting dose and is typically not effective for blood sugar control; 

Trulicity 0.75 mg injection is a prescription, once-weekly, single-dose, pre-filled pen containing the active ingredient dulaglutide. It is a clear, colorless solution administered subcutaneously to help manage type 2 diabetes and reduce the risk of major cardiovascular events in adults. 

Rybelsus 14mg tablets contain semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes, in addition to diet and exercise

Trulicity 1.5 mg is a clear, colorless solution of the active ingredient dulaglutide contained in a disposable, pre-filled, single-use pen for subcutaneous injection. It is an anti-diabetic medication used primarily to treat Type 2 diabetes.